188 related articles for article (PubMed ID: 36038819)
1. A diagnosis model in nasopharyngeal carcinoma based on PET/MRI radiomics and semiquantitative parameters.
Feng Q; Liang J; Wang L; Ge X; Ding Z; Wu H
BMC Med Imaging; 2022 Aug; 22(1):150. PubMed ID: 36038819
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F
PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364
[TBL] [Abstract][Full Text] [Related]
3. Multimodality radiomics analysis based on [
Xu H; Lv W; Zhang H; Yuan Q; Wang Q; Wu Y; Lu L
Eur Radiol; 2023 Oct; 33(10):6677-6688. PubMed ID: 37060444
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
[TBL] [Abstract][Full Text] [Related]
5. MRI-based radiomics nomogram for predicting temporal lobe injury after radiotherapy in nasopharyngeal carcinoma.
Hou J; Li H; Zeng B; Pang P; Ai Z; Li F; Lu Q; Yu X
Eur Radiol; 2022 Feb; 32(2):1106-1114. PubMed ID: 34467454
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
Li Q; Zhang J; Cheng W; Zhu C; Chen L; Xia F; Wang M; Yang F; Ma X
Medicine (Baltimore); 2017 Sep; 96(37):e8084. PubMed ID: 28906411
[TBL] [Abstract][Full Text] [Related]
8. Radiomics Analysis and Correlation With Metabolic Parameters in Nasopharyngeal Carcinoma Based on PET/MR Imaging.
Feng Q; Liang J; Wang L; Niu J; Ge X; Pang P; Ding Z
Front Oncol; 2020; 10():1619. PubMed ID: 33014815
[No Abstract] [Full Text] [Related]
9. Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma.
Zhang B; Tian J; Dong D; Gu D; Dong Y; Zhang L; Lian Z; Liu J; Luo X; Pei S; Mo X; Huang W; Ouyang F; Guo B; Liang L; Chen W; Liang C; Zhang S
Clin Cancer Res; 2017 Aug; 23(15):4259-4269. PubMed ID: 28280088
[No Abstract] [Full Text] [Related]
10. Cervical spine osteoradionecrosis or bone metastasis after radiotherapy for nasopharyngeal carcinoma? The MRI-based radiomics for characterization.
Zhong X; Li L; Jiang H; Yin J; Lu B; Han W; Li J; Zhang J
BMC Med Imaging; 2020 Sep; 20(1):104. PubMed ID: 32873238
[TBL] [Abstract][Full Text] [Related]
11. Differences in Radiomics Signatures Between Patients with Early and Advanced T-Stage Nasopharyngeal Carcinoma Facilitate Prognostication.
Wu S; Li H; Dong A; Tian L; Ruan G; Liu L; Shao Y
J Magn Reson Imaging; 2021 Sep; 54(3):854-865. PubMed ID: 33830573
[TBL] [Abstract][Full Text] [Related]
12. Machine Learning Methods for Optimal Radiomics-Based Differentiation Between Recurrence and Inflammation: Application to Nasopharyngeal Carcinoma Post-therapy PET/CT Images.
Du D; Feng H; Lv W; Ashrafinia S; Yuan Q; Wang Q; Yang W; Feng Q; Chen W; Rahmim A; Lu L
Mol Imaging Biol; 2020 Jun; 22(3):730-738. PubMed ID: 31338709
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma.
Peng H; Dong D; Fang MJ; Li L; Tang LL; Chen L; Li WF; Mao YP; Fan W; Liu LZ; Tian L; Lin AH; Sun Y; Tian J; Ma J
Clin Cancer Res; 2019 Jul; 25(14):4271-4279. PubMed ID: 30975664
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
Huang Y; Feng M; He Q; Yin J; Xu P; Jiang Q; Lang J
Medicine (Baltimore); 2017 Apr; 96(17):e6721. PubMed ID: 28445287
[TBL] [Abstract][Full Text] [Related]
15. Establishment and validation of a nomogram with intratumoral heterogeneity derived from
Gu B; Zhang J; Ma G; Song S; Shi L; Zhang Y; Yang Z
BMC Cancer; 2020 Jan; 20(1):37. PubMed ID: 31941465
[TBL] [Abstract][Full Text] [Related]
16. Radiomics Analysis of PET and CT Components of PET/CT Imaging Integrated with Clinical Parameters: Application to Prognosis for Nasopharyngeal Carcinoma.
Lv W; Yuan Q; Wang Q; Ma J; Feng Q; Chen W; Rahmim A; Lu L
Mol Imaging Biol; 2019 Oct; 21(5):954-964. PubMed ID: 30671740
[TBL] [Abstract][Full Text] [Related]
17. A MRI-based radiomics model predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma.
Bao D; Zhao Y; Li L; Lin M; Zhu Z; Yuan M; Zhong H; Xu H; Zhao X; Luo D
Eur Radiol; 2022 Oct; 32(10):6910-6921. PubMed ID: 35639143
[TBL] [Abstract][Full Text] [Related]
18. Robustness versus disease differentiation when varying parameter settings in radiomics features: application to nasopharyngeal PET/CT.
Lv W; Yuan Q; Wang Q; Ma J; Jiang J; Yang W; Feng Q; Chen W; Rahmim A; Lu L
Eur Radiol; 2018 Aug; 28(8):3245-3254. PubMed ID: 29520429
[TBL] [Abstract][Full Text] [Related]
19. Lymph node standardized uptake values at pre-treatment
Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
[TBL] [Abstract][Full Text] [Related]
20. Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups.
Zhuo EH; Zhang WJ; Li HJ; Zhang GY; Jing BZ; Zhou J; Cui CY; Chen MY; Sun Y; Liu LZ; Cai HM
Eur Radiol; 2019 Oct; 29(10):5590-5599. PubMed ID: 30874880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]